MarketCapTrends
ABVC

ABVC BioPharma Inc. (ABVC)

NASDAQ · Healthcare

ABVC BioPharma Inc. annual/quarterly total liabilities history from 2015 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.

  • ABVC BioPharma Inc. total liabilities for the quarter ending December 31, 2025 were 7.8M, a 13.92% increase year-over-year.
  • ABVC BioPharma Inc. total liabilities for 2025 were 7.8M, a 13.92% increase from 2024.
  • ABVC BioPharma Inc. total liabilities for 2024 were 6.8M, a 4.36% increase from 2023.
  • ABVC BioPharma Inc. total liabilities for 2023 were 6.5M, a 2.96% increase from 2022.
  • ABVC BioPharma Inc. total liabilities for 2022 were 6.3M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
ABVC BioPharma Inc. Annual Total Liabilities (Millions of US $)
2025$8
2024$7
2023$7
2022$6
2021$5
2020$9
2019$7
2018$11
2015$0
ABVC BioPharma Inc. Quarterly Total Liabilities (Millions of US $)
2025-12-31$8
2024-12-31$7
2023-12-31$7
2022-12-31$6
2021-12-31$5
2020-12-31$9
2019-12-31$7
2018-12-31$11
2015-09-30$0

ABVC BioPharma Inc. Total Liabilities — FAQ

ABVC BioPharma Inc. (ABVC) total liabilities over the last 15 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see ABVC's total liabilities history?

The chart and table above show ABVC BioPharma Inc.'s total liabilities by year and by quarter, including the growth rate.